14-day Premium Trial Subscription Sign Up For FreeGet Free

Celsion Corporation Stock Forecast NASDAQ:CLSN

Price Target and Analyst Ratings

Most Recent Rating

Dawson James is very positive about CLSN and gave it a "Buy" rating on June 24, 2020. The price target was set to $4.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-07-16 Outperform - Market Perform Downgraded by Oppenheimer $1.09
2020-07-13 Buy - Neutral Downgraded by Dawson James $1.29
2020-06-24 Buy Reiterated by Dawson James $4.26 $4.00

CLSN Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -16.74% during the next 3 months and, with a 90% probability hold a price between $0.72 and $0.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $0.86 $0.98 $1.11
2021-09-23 $0.86 $0.98 $1.10
2021-09-24 $0.85 $0.98 $1.10
2021-09-27 $0.85 $0.97 $1.10
2021-09-28 $0.85 $0.97 $1.09
2021-09-29 $0.84 $0.97 $1.09
2021-09-30 $0.84 $0.96 $1.09
2021-10-01 $0.83 $0.96 $1.08
2021-10-04 $0.83 $0.96 $1.08
2021-10-05 $0.83 $0.95 $1.08
2021-10-06 $0.82 $0.95 $1.07
2021-10-07 $0.82 $0.94 $1.07
2021-10-08 $0.82 $0.94 $1.06
2021-10-11 $0.81 $0.94 $1.06
2021-10-12 $0.81 $0.93 $1.06
2021-10-13 $0.81 $0.93 $1.05
2021-10-14 $0.80 $0.93 $1.05
2021-10-15 $0.80 $0.92 $1.05
2021-10-18 $0.80 $0.92 $1.04
2021-10-19 $0.79 $0.92 $1.04
2021-10-20 $0.79 $0.91 $1.04
2021-10-21 $0.78 $0.91 $1.03
2021-10-22 $0.78 $0.91 $1.03
2021-10-25 $0.78 $0.90 $1.03
2021-10-26 $0.77 $0.90 $1.02
2021-10-27 $0.77 $0.89 $1.02
2021-10-28 $0.77 $0.89 $1.02
2021-10-29 $0.76 $0.89 $1.01
2021-11-01 $0.76 $0.88 $1.01
2021-11-02 $0.76 $0.88 $1.00

About Celsion Corporation

Celsion Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company’s lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It has a developme... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT